GCM
HLVX

Ghisallo Capital Management’s HilleVax HLVX Stock Holding History

Ghisallo Capital Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,000
Closed -$202K – 141
2023
Q3 		$202K Buy
+15,000
New +$211K 0.02% 109
2022
Q3 		– Sell
-60,000
Closed -$656K – 259
2022
Q2 		$656K Buy
+60,000
New +$712K 0.08% 251

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ghisallo Capital Management's HLVX Position: Q4 2023 in Review

Ghisallo Capital Management sold out of HilleVax (HLVX) in Q4 2023, closing a stake of 15,000 shares — an estimated $202K sold.

Ghisallo Capital Management first reported a position in HLVX in Q2 2022 and held it in 2 quarters. The position peaked at $656K in Q2 2022. 69 funds tracked by Wall St. Rank hold HLVX as of Q4 2023.

  • Ghisallo Capital Management reported no remaining HilleVax position as of Q4 2023 after selling out during the quarter.
  • Ghisallo Capital Management sold 15,000 HilleVax shares in Q4 2023, an estimated $202K.
  • Ghisallo Capital Management first reported a position in HilleVax in Q2 2022 and held it in 2 quarters.
  • Ghisallo Capital Management's HilleVax position peaked at $656K in Q2 2022.
  • 69 funds tracked by Wall St. Rank held HilleVax as of Q4 2023.

Based on Ghisallo Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.